Harbour Investments’s Pacer BioThreat Strategy ETF VIRS Stock Holding History

Harbour Investments’s Portfolio VIRS Stock Details VIRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-608	Closed	-$18K	–	4021
2021 Q1	$18K	Buy	+608	New	+$17.6K	﹤0.01%	2285

Other funds holding VIRS

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments's VIRS Position: Q2 2021 in Review

Harbour Investments sold out of Pacer BioThreat Strategy ETF (VIRS) in Q2 2021, closing a stake of 608 shares — an estimated $18K sold.

Harbour Investments first reported a position in VIRS in Q1 2021 and held it in 1 quarter. The position peaked at $18K in Q1 2021. 5 funds tracked by Wall St. Rank hold VIRS as of Q2 2021.

Harbour Investments reported no remaining Pacer BioThreat Strategy ETF position as of Q2 2021 after selling out during the quarter.
Harbour Investments sold 608 Pacer BioThreat Strategy ETF shares in Q2 2021, an estimated $18K.
Harbour Investments first reported a position in Pacer BioThreat Strategy ETF in Q1 2021 and held it in 1 quarter.
Harbour Investments's Pacer BioThreat Strategy ETF position peaked at $18K in Q1 2021.
5 funds tracked by Wall St. Rank held Pacer BioThreat Strategy ETF as of Q2 2021.

Based on Harbour Investments's 13F filing for Q2 2021, filed 16 Aug 2021.